A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease
Clinical trial NCT05343364 · COMPLETED
Trial details
- NCT number
- NCT05343364
- Sponsor
- Phathom Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-09
- Primary completion
- 2023-05-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.